The Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases

DSpace/Manakin Repository

The Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Stennes, Matthew L. en_US
dc.date.accessioned 2012-08-23T11:11:50Z
dc.date.issued 1997 en_US
dc.identifier.citation The Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases (1997 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:9453691
dc.description.abstract Najarian and Burzynski seem the perfect examples of the amazing potential of the American medical establishment. Their visionary work in their respective fields should be celebrated as monumental contributions to society. Rather than being lauded by the nation, though, both men have watched their careers and reputations come hurtling to a disastrous end as they faced criminal charges of fraud, embezzlement, and multiple violations of Food and Drug Administration (FDA) laws which threatened to send them each to prison for the rest of their lives. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject FDA misdirection en
dc.subject regulation of physician prescribing en
dc.subject human drugs en
dc.subject Najarian en
dc.subject Burzynski en
dc.title The Criminalization of Innovation: FDA Misdirection in the Najarian and Burzynski Cases en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-08-23T11:11:50Z

Files in this item

Files Size Format View
mstennes.pdf 217.5Kb PDF View/Open
mstennes.rtf 54.29Kb RTF file View/Open
mstennes.html 56.18Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters